Literature DB >> 12242308

Mechanism of e47-Pip interaction on DNA resulting in transcriptional synergy and activation of immunoglobulin germ line sterile transcripts.

Sujatha Nagulapalli1, Aisha Goheer, Leslie Pitt, Lawrence P McIntosh, Michael L Atchison.   

Abstract

E47 and Pip are proteins crucial for proper B-cell development. E47 and Pip cooperatively bind to adjacent sites in the immunoglobulin kappa chain 3' enhancer and generate a potent transcriptional synergy. We generated protein-DNA computer models to visualize E47 and Pip bound to DNA. These models predict precise interactions between the two proteins. We tested predictions deduced from these models by mutagenesis studies and found evidence for novel direct interactions between the E47 helix-loop-helix domain (Arg 357 or Asp 358) and the Pip N terminus (Leu 24). We also found that precise spatial alignment of the binding sites was necessary for transcriptional synergy and cooperative DNA binding. A Pip dominant negative mutant that cannot synergize with E47 inhibited enhancer activity in plasmacytoma cells and could not activate transcription in pre-B cells. Using electrophoretic mobility shift assays, we found that Pip can bind to the heavy-chain intron enhancer region. In addition, we found that in fibroblasts Pip greatly increased E47 induction of germ line I micro transcripts associated with somatic rearrangement and isotype class switching. However, a Pip dominant negative mutant inhibited germ line I micro transcripts. The importance of these results for late B-cell functions is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12242308      PMCID: PMC139794          DOI: 10.1128/MCB.22.20.7337-7350.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  71 in total

1.  EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes.

Authors:  M Sigvardsson; M O'Riordan; R Grosschedl
Journal:  Immunity       Date:  1997-07       Impact factor: 31.745

2.  Potential regulatory elements for germline transcription in or near murine Sgamma1.

Authors:  K Cunningham; H Ackerly; F Alt; W Dunnick
Journal:  Int Immunol       Date:  1998-04       Impact factor: 4.823

3.  CD40 ligand exerts differential effects on the expression of I gamma transcripts in subclones of an IgM+ human B cell lymphoma line.

Authors:  G S Ford; C H Yin; B Barnhart; K Sztam; L R Covey
Journal:  J Immunol       Date:  1998-01-15       Impact factor: 5.422

4.  Structure of IRF-1 with bound DNA reveals determinants of interferon regulation.

Authors:  C R Escalante; J Yie; D Thanos; A K Aggarwal
Journal:  Nature       Date:  1998-01-01       Impact factor: 49.962

5.  Transcriptional synergy between LIM-homeodomain proteins and basic helix-loop-helix proteins: the LIM2 domain determines specificity.

Authors:  J D Johnson; W Zhang; A Rudnick; W J Rutter; M S German
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

6.  CD40 cross-linking induces Ig epsilon germline transcripts in B cells via activation of NF-kappaB: synergy with IL-4 induction.

Authors:  L A Iciek; S A Delphin; J Stavnezer
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

7.  Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation.

Authors:  J M Pongubala; C Van Beveren; S Nagulapalli; M J Klemsz; S R McKercher; R A Maki; M L Atchison
Journal:  Science       Date:  1993-03-12       Impact factor: 47.728

8.  Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function.

Authors:  H W Mittrücker; T Matsuyama; A Grossman; T M Kündig; J Potter; A Shahinian; A Wakeham; B Patterson; P S Ohashi; T W Mak
Journal:  Science       Date:  1997-01-24       Impact factor: 47.728

9.  Deletion of the immunoglobulin kappa chain intron enhancer abolishes kappa chain gene rearrangement in cis but not lambda chain gene rearrangement in trans.

Authors:  S Takeda; Y R Zou; H Bluethmann; D Kitamura; U Muller; K Rajewsky
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

10.  V(D)J recombination in B cells is impaired but not blocked by targeted deletion of the immunoglobulin heavy chain intron enhancer.

Authors:  M Serwe; F Sablitzky
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

View more
  11 in total

1.  NFAT and IRF proteins regulate transcription of the anti-HIV gene, APOBEC3G.

Authors:  Melissa A Farrow; Eun-Young Kim; Steven M Wolinsky; Ann M Sheehy
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

2.  A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.

Authors:  Suchita Hodawadekar; Kyoungsook Park; Michael A Farrar; Michael L Atchison
Journal:  J Immunol       Date:  2012-01-25       Impact factor: 5.422

3.  E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells.

Authors:  Adam S Lazorchak; Mark S Schlissel; Yuan Zhuang
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

4.  Epigenetic histone modifications do not control Igkappa locus contraction and intranuclear localization in cells with dual B cell-macrophage potential.

Authors:  Suchita Hodawadekar; Fang Wei; Duonan Yu; Andrei Thomas-Tikhonenko; Michael L Atchison
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

5.  B-cell receptor activation inhibits AID expression through calmodulin inhibition of E-proteins.

Authors:  Jannek Hauser; Natalia Sveshnikova; Anders Wallenius; Sanna Baradaran; Juha Saarikettu; Thomas Grundström
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-18       Impact factor: 11.205

6.  A role for interferon regulatory factor 4 in receptor editing.

Authors:  Simanta Pathak; Shibin Ma; Long Trinh; Runqing Lu
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

Review 7.  IRF4: Immunity. Malignancy! Therapy?

Authors:  Arthur L Shaffer; N C Tolga Emre; Paul B Romesser; Louis M Staudt
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

8.  Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development.

Authors:  Shibin Ma; Simanta Pathak; Long Trinh; Runqing Lu
Journal:  Blood       Date:  2007-10-30       Impact factor: 22.113

Review 9.  Interferon regulatory factor 4 and 8 in B-cell development.

Authors:  Runqing Lu
Journal:  Trends Immunol       Date:  2008-09-03       Impact factor: 16.687

10.  PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells.

Authors:  Fang Wei; Kristina Zaprazna; Junwen Wang; Michael L Atchison
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.